Pathways to understanding the genomic aetiology of osteoarthritis

Human Molecular Genetics

Volumn 26, Issue R2, 2017, Pages R193-R201

  Uhalte, Elena Cibrián ^a   Wilkinson, Jeremy Mark ^b   Southam, Lorraine ^a,c   Zeggini, Eleftheria ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; GENETIC DISORDER; GENOMICS; HUMAN; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RARE DISEASE; REVIEW; DISEASE EXACERBATION; GENETICS; PHYSIOLOGY; PROCEDURES; RISK FACTOR; SYNOVIAL FLUID;

DISEASE PROGRESSION; GENOMICS; HUMANS; OSTEOARTHRITIS; RISK FACTORS; SYNOVIAL FLUID;

EID: 85030711717     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddx302     Document Type: Review

References (107)

1. Vos, T., Flaxman, A.D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J.A., Abdalla, S., Aboyans, V. et al. (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2163-2196
2. Murray, C.J., Vos, T., Lozano, R., Naghavi, M., Flaxman, A.D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J.A., Abdalla, S. et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2197-2223
3. Cross, M., Smith, E., Hoy, D., Nolte, S., Ackerman, I., Fransen, M., Bridgett, L., Williams, S., Guillemin, F., Hill, C.L. et al. (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann. Rheum. Dis., 73, 1323-1330
4. Kingsbury, S.R., Gross, H.J., Isherwood, G. and Conaghan, P.G. (2014) Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries. Rheumatology (Oxford), 53, 937-947
5. Hilingsmann, M. and Reginster, J.-Y. The economic weight of osteoarthritis in Europe http://www.medicographia. com/2013/10/the-economic-weight-of-osteoarthritis-ineurope/; date last accessed August 08, 2017
6. Dieppe, P.A. and Lohmander, L.S. (2005) Pathogenesis and management of pain in osteoarthritis. Lancet, 365, 965-973
7. Hiligsmann, M., Cooper, C., Arden, N., Boers, M., Branco, J.C., Luisa Brandi, M., Bruyère, O., Guillemin, F., Hochberg, M.C., Hunter, D.J. et al. (2013) Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin. Arthritis Rheum., 43, 303-313
8. Arthritis Research UK. Osteoarthritis in General Practice: Data and Perspectives. 2013
9. Murphy, L., Schwartz, T.A., Helmick, C.G., Renner, J.B., Tudor, G., Koch, G., Dragomir, A., Kalsbeek, W.D., Luta, G. and Jordan, J.M. (2008) Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum., 59, 1207-1213
10. Eurostat: Surgical operations and procedures performed in hospitals. http://appsso.eurostat.ec.europa.eu/nui/show. do?dataset=hlth_co_proc2&lang=en; date last accessed August 08, 2017
11. Robertsson, O., Dunbar, M., Pehrsson, T., Knutson, K. and Lidgren, L. (2000) Patient satisfaction after knee arthroplasty: a report on 27, 372 knees operated on between 1981 and 1995 in Sweden. Acta Orthop. Scand., 71, 262-267
12. Baker, P.N., van der Meulen, J.H., Lewsey, J. and Gregg, P.J. (2007) National Joint Registry for E, Wales. The role of pain and function in determining patient satisfaction after total knee replacement. Data from the National Joint Registry for England and Wales. J. Bone Joint Surg. Br., 89, 893-900
13. Baker, P.N., Deehan, D.J., Lees, D., Jameson, S., Avery, P.J., Gregg, P.J. and Reed, M.R. (2012) The effect of surgical factors on early patient-reported outcome measures (PROMS) following total knee replacement. J. Bone Joint Surg. Br., 94, 1058-1066
14. Hunter, D.J. (2011) Pharmacologic therapy for osteoarthritis-the era of disease modification. Nat. Rev. Rheumatol., 7, 13-22
15. Scanzello, C.R. and Goldring, S.R. (2012) The role of synovitis in osteoarthritis pathogenesis. Bone, 51, 249-257
16. Goldring, S.R. and Goldring,M.B. (2016) Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. Nat. Rev. Rheumatol., 12, 632-644
17. Man, G.S. and Mologhianu, G. (2014) Osteoarthritis pathogenesis-a complex process that involves the entire joint. J. Med. Life, 7, 37-41
18. Glyn-Jones, S., Palmer, A.J., Agricola, R., Price, A.J., Vincent, T.L., Weinans, H. and Carr, A.J.R. (2015) Osteoarthritis. Lancet, 386, 376-387
19. Felson, D.T., Naimark, A., Anderson, J., Kazis, L., Castelli, W. and Meenan, R.F. (1987) The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis. Rheum., 30, 914-918
20. Dillon, C.F., Rasch, E.K., Gu, Q. and Hirsch, R. (2006) Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J. Rheumatol., 33, 2271-2279
21. van Saase, J.L., van Romunde, L.K., Cats, A., Vandenbroucke, J.P. and Valkenburg, H.A. (1989) Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann. Rheum. Dis., 48, 271-280
22. Oliveria, S.A., Felson, D.T., Reed, J.I., Cirillo, P.A. and Walker, A.M. (1995) Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis. Rheum., 38, 1134-1141
23. Felson, D.T., Zhang, Y., Hannan, M.T., Naimark, A., Weissman, B., Aliabadi, P. and Levy, D. (1997) Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum., 40, 728-733
24. Anderson, J.J. and Felson, D.T. (1988) Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands. Am. J. Epidemiol., 128, 179-189
25. Cooper, C., Snow, S., McAlindon, T.E., Kellingray, S., Stuart, B., Coggon, D. and Dieppe, P.A. (2000) Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis. Rheum., 43, 995-1000
26. Blagojevic, M., Jinks, C., Jeffery, A. and Jordan, K.P. (2010) Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthr. Cartil., 18, 24-33
27. Spector, T.D., Cicuttini, F., Baker, J., Loughlin, J. and Hart, D. (1996) Genetic influences on osteoarthritis in women: a twin study [see comments]. BMJ, 312, 940-943
28. Spector, T.D. and MacGregor, A.J. (2004) Risk factors for osteoarthritis: genetics. Osteoarthr. Cartil., 12 Suppl A, S39-S44
29. MacGregor, A.J., Li, Q., Spector, T.D. and Williams, F.M. (2009) The genetic influence on radiographic osteoarthritis is site specific at the hand, hip and knee. Rheumatology (Oxford), 48, 277-280
30. Valdes, A.M. and Spector, T.D. (2011) Genetic epidemiology of hip and knee osteoarthritis. Nat. Rev. Rheumatol., 7, 23-32
31. Styrkarsdottir, U., Helgason, H., Sigurdsson, A., Norddahl, G.L., Agustsdottir, A.B., Reynard, L.N., Villalvilla, A., Halldorsson, G.H., Jonasdottir, A., Magnusdottir, A. et al. (2017) Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritis. Nat. Genet., 49, 801-805
32. Acharya, C., Yik, J.H., Kishore, A., Van Dinh, V., Di Cesare, P.E. and Haudenschild, D.R. (2014) Cartilage oligomeric matrix protein and its binding partners in the cartilage extracellular matrix: interaction, regulation and role in chondrogenesis. Matrix Biol., 37, 102-111
33. Das, B.R., Roy, A. and Khan, F.R. (2015) Cartilage oligomeric matrix protein in monitoring and prognostication of osteoarthritis and its utility in drug development. Perspect. Clin. Res., 6, 4-9
34. Verma, P. and Dalal, K. (2013) Serum cartilage oligomericmatrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker. J. Orthop. Res., 31, 999-1006
35. Tillgren, V., Ho, J.C., Onnerfjord, P. and Kalamajski, S. (2015) The novel small leucine-rich protein chondroadherin-like (CHADL) is expressed in cartilage and modulates chondrocyte differentiation. J. Biol. Chem., 290, 918-925
36. Hackinger, S., Trajanoska, K., Styrkarsdottir, U., Zengini, E., Steinberg, S., Ritchie, G.R.S., Hatzikotoulas, K., Gilly, A., Evangelou, E., Kemp, J.P. et al. (2017) Evaluation of shared genetic aetiology between osteoarthritis and bone mineral density identifies SMAD3 as a novel osteoarthritis risk locus. Hum. Mol. Genet, 26, 3850-3858
37. Zeggini, E., Panoutsopoulou, K., Southam, L., Rayner, N.W., Day-Williams, A.G., Lopes, M.C., Boraska, V., Esko, T., Evangelou, E., Hoffman, A., arcOGEN Consortium, arcOgen Collaborators. et al. (2012) Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet, 380, 815-823
38. Freilinger, T., Anttila, V., de Vries, B., Malik, R., Kallela, M., Terwindt, G.M., Pozo-Rosich, P., Winsvold, B., Nyholt, D.R., van Oosterhout, W.P. et al. (2012) Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat. Genet., 44, 777-782
39. Uebelhart, D. (2008) Clinical review of chondroitin sulfate in osteoarthritis. Osteoarthritis Cartilage, 16 Suppl 3, S19-S21
40. Esbrit, P., Herrera, S., Portal-Nunez, S., Nogues, X. and Diez-Perez, A. (2016) Parathyroid hormone-related protein analogs as osteoporosis therapies. Calcif. Tissue Int., 98, 359-369
41. Bonjour, J.P. and Fleisch, H.A. (1973) Diphosphonates and vitamin-Dmetabolismin Paget's disease. Lancet, 2, 375-376
42. Fleisch, H. and Bisaz, S. (1962) Mechanism of calcification: inhibitory role of pyrophosphate. Nature, 195, 911
43. Thomas, J.T., Lin, K., Nandedkar, M., Camargo, M., Cervenka, J. and Luyten, F.P. (1996) A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nat. Genet., 12, 315-317
44. Rouault, K., Scotet, V., Autret, S., Gaucher, F., Dubrana, F., Tanguy, D., El Rassi, C.Y., Fenoll, B. and Férec, C. (2010) Evidence of association between GDF5 polymorphisms and congenital dislocation of the hip in a Caucasian population. Osteoarthr. Cartil., 18, 1144-1149
45. Stahl, P.L., Salmen, F., Vickovic, S., Lundmark, A., Navarro, J.F., Magnusson, J., Giacomello, S., Asp, M., Westholm, J.O., Huss, M. et al. (2016) Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science, 353, 78-82
46. Mortazavi, A., Williams, B.A., McCue, K., Schaeffer, L. and Wold, B. (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods, 5, 621-628
47. Nagalakshmi, U., Wang, Z., Waern, K., Shou, C., Raha, D., Gerstein, M. and Snyder, M. (2008) The transcriptional landscape of the yeast genome defined by RNA sequencing. Science, 320, 1344-1349
48. Buenrostro, J.D., Giresi, P.G., Zaba, L.C., Chang, H.Y. and Greenleaf, W.J. (2013) Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods, 10, 1213-1218
49. Dekker, J., Marti-Renom, M.A. and Mirny, L.A. (2013) Exploring the three-dimensional organization of genomes: interpreting chromatin interaction data. Nat. Rev. Genet., 14, 390-403
50. Encode Project Consortium(2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74
51. Stunnenberg, H.G., International Human Epigenome, C. and Hirst, M. (2016) The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery. Cell, 167, 1145-1149
52. Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., Ziller, M.J. et al. (2015) Integrative analysis of 111 reference human epigenomes. Nature, 518, 317-330
53. Meulenbelt, I.M., Bhutani, N., den Hollander, W., Gay, S., Oppermann, U., Reynard, L.N., Skelton, A.J., Young, D.A., Beier, F. and Loughlin, J. (2017) The first international workshop on the epigenetics of osteoarthritis. Connect. Tissue Res., 58, 37-48
54. Steinberg, J. and Zeggini, E. (2016) Functional Genomics in Osteoarthritis: Past, Present, and Future. J. Orthop. Res., 34, 1105-1110
55. Jeffries, M.A., Donica, M., Baker, L.W., Stevenson, M.E., Annan, A.C., Humphrey, M.B., James, J.A. and Sawalha, A.H. (2014) Genome-wide DNA methylation study identifies significant epigenomic changes in osteoarthritic cartilage. Arthritis Rheumatol., 66, 2804-2815
56. Moazedi-Fuerst, F.C., Hofner, M., Gruber, G., Weinhaeusel, A., Stradner, M.H., Angerer, H., Peischler, D., Lohberger, B., Glehr, M., Leithner, A. et al. (2014) Epigenetic differences in human cartilage between mild and severe OA. J. Orthop. Res., 32, 1636-1645
57. den Hollander, W., Ramos, Y.F., Bos, S.D., Bomer, N., van der Breggen, R., Lakenberg, N., de Dijcker, W.J., Duijnisveld, B.J., Slagboom, P.E., Nelissen, R.G. et al. (2014) Knee and hip articular cartilage have distinct epigenomic landscapes: implications for future cartilage regeneration approaches. Ann. Rheum. Dis., 73, 2208-2212
58. Steinberg, J., Ritchie, G.R.S., Roumeliotis, T.I., Jayasuriya, R.L., Brooks, R.A., Binch, A.L.A., Shah, K.M., Coyle, R., Pardo, M., Le Maitre, C.L. et al. Integrative epigenomics, transcriptomics and proteomics of patient chondrocytes reveal genes and pathways involved in osteoarthritis. bioRxiv 2016, doi: https://doi.org/10.1101/038067
59. Karlsson, C., Dehne, T., Lindahl, A., Brittberg, M., Pruss, A., Sittinger, M. and Ringe, J. (2010) Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis. Osteoarthr. Cartil., 18, 581-592
60. Tew, S.R., McDermott, B.T., Fentem, R.B., Peffers, M.J. and Clegg, P.D. (2014) Transcriptome-wide analysis of messenger RNA decay in normal and osteoarthritic human articular chondrocytes. Arthritis Rheumatol., 66, 3052-3061
61. Stenberg, J., Rüetschi, U., Skiöldebrand, E., Kärrholm, J. and Lindahl, A. (2013) Quantitative proteomics reveals regulatory differences in the chondrocyte secretome from human medial and lateral femoral condyles in osteoarthritic patients. Proteome Sci., 11, 43
62. Ruiz-Romero, C., Fernandez-Puente, P., Calamia, V. and Blanco, F.J. (2015) Lessons from the proteomic study of osteoarthritis. Expert Rev. Proteomics, 12, 433-443
63. Chou, C.H., Lee, M.T., Song, I.W., Lu, L.S., Shen, H.C., Lee, C.H., Wu, J.Y., Chen, Y.T., Kraus, V.B. and Wu, C.C. (2015) Insights into osteoarthritis progression revealed by analyses of both knee tibiofemoral compartments. Osteoarthr. Cartil., 23, 571-580
64. Delgado-Calle, J., Fernańdez, A.F., Sainz, J., Zarrabeitia, M.T., Sañudo, C., Garciá-Renedo, R., Pérez-Núñez, M.I., Garciá-Ibarbia, C., Fraga, M.F. and Riancho, J.A. (2013) Genome-wide profiling of bone reveals differentially methylated regions in osteoporosis and osteoarthritis. Arthritis Rheumatol., 65, 197-205
65. Fernańdez-Tajes, J., Soto-Hermida, A., Vaźquez-Mosquera, M.E., Cortés-Pereira, E., Mosquera, A., Fernańdez-Moreno, M., Oreiro, N., Fernańdez-López, C., Fernańdez, J.L., Rego-Pérez, I. and Blanco, F.J. (2014) Genome-wide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients. Ann. Rheum. Dis., 73, 668-677
66. Gobezie, R., Kho, A., Krastins, B., Sarracino, D.A., Thornhill, T.S., Chase, M., Millett, P.J. and Lee, D.M. (2007) High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res. Ther., 9, R36
67. Hopwood, B., Tsykin, A., Findlay, D.M. and Fazzalari, N.L. (2007) Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling. Arthritis Res. Ther., 9, R100
68. Lamas, J.R., Rodríguez-Rodríguez, L., Vigo, A.G., Alvarez-Lafuente, R., López-Romero, P., Marco, F., Camafeita, E., Dopazo, A., Callejas, S., Villafuertes, E. et al. (2010) Large-scale gene expression in bone marrow mesenchymal stem cells: a putative role for COL10A1 in osteoarthritis. Ann. Rheum. Dis., 69, 1880-1885
69. Lambert, C., Dubuc, J.E., Montell, E., Vergés, J., Munaut, C., Noël, A. and Henrotin, Y. (2014) Gene expression pattern of cells from inflamed and normal areas of osteoarthritis synovial membrane. Arthritis Rheumatol., 66, 960-968
70. Ritter, S.Y., Subbaiah, R., Bebek, G., Crish, J., Scanzello, C.R., Krastins, B., Sarracino, D., Lopez, M.F., Crow, M.K., Aigner, T. et al. (2013) Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues. Arthritis Rheumatol., 65, 981-992
71. Rushton, M.D., Reynard, L.N., Barter, M.J., Refaie, R., Rankin, K.S., Young, D.A. and Loughlin, J. (2014) Characterization of the cartilage DNA methylome in knee and hip osteoarthritis. Arthritis Rheumatol., 66, 2450-2460
72. Xu, Y., Barter, M.J., Swan, D.C., Rankin, K.S., Rowan, A.D., Santibanez-Koref, M., Loughlin, J. and Young, D.A. (2012) Identification of the pathogenic pathways in osteoarthritic hip cartilage: commonality and discord between hip and knee OA. Osteoarthr. Cartil., 20, 1029-1038
73. Martin, P., McGovern, A., Orozco, G., Duffus, K., Yarwood, A., Schoenfelder, S., Cooper, N.J., Barton, A., Wallace, C., Fraser, P. et al. (2015) Capture Hi-C reveals novel candidate genes and complex long-range interactions with related autoimmune risk loci. Nat. Commun., 6, 10069
74. McGovern, A., Schoenfelder, S., Martin, P., Massey, J., Duffus, K., Plant, D., Yarwood, A., Pratt, A.G., Anderson, A.E., Isaacs, J.D. et al. (2016) Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23. Genome Biol., 17, 212
75. Zengini, E., Finan, C. and Wilkinson, J.M. (2016) The genetic epidemiological landscape of hip and knee osteoarthritis: where are we now and where are we going?. J. Rheumatol., 43, 260-266
76. Pickrell, J.K. (2014) Joint analysis of functional genomic data and genome-wide association studies of 18 human traits. Am. J. Hum. Genet., 94, 559-573
77. Welter, D., MacArthur, J., Morales, J., Burdett, T., Hall, P., Junkins, H., Klemm, A., Flicek, P., Manolio, T., Hindorff, L. et al. (2014) The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res., 42, D1001-D1006
78. Hindorff, L.A., Sethupathy, P., Junkins, H.A., Ramos, E.M., Mehta, J.P., Collins, F.S. and Manolio, T.A. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U.S.A, 106, 9362-9367
79. McVicker, G., van de Geijn, B., Degner, J.F., Cain, C.E., Banovich, N.E., Raj, A., Lewellen, N., Myrthil, M., Gilad, Y. and Pritchard, J.K. (2013) Identification of genetic variants that affect histone modifications in human cells. Science, 342, 747-749
80. Ernst, J., Kheradpour, P., Mikkelsen, T.S., Shoresh, N., Ward, L.D., Epstein, C.B., Zhang, X., Wang, L., Issner, R., Coyne, M. et al. (2011) Mapping and analysis of chromatin state dynamics in nine human cell types. Nature, 473, 43-49
81. Schaub, M.A., Boyle, A.P., Kundaje, A., Batzoglou, S. and Snyder, M. (2012) Linking disease associations with regulatory information in the human genome. Genome Res., 22, 1748-1759
82. Miyamoto, Y., Mabuchi, A., Shi, D., Kubo, T., Takatori, Y., Saito, S., Fujioka, M., Sudo, A., Uchida, A., Yamamoto, S. et al. (2007) A functional polymorphism in the 5' UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat. Genet., 39, 529-533
83. Reynard, L.N., Bui, C., Canty-Laird, E.G., Young, D.A. and Loughlin, J. (2011) Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation. Hum. Mol. Genet., 20, 3450-3460
84. Syddall, C.M., Reynard, L.N., Young, D.A. and Loughlin, J. (2013) The identification of trans-acting factors that regulate the expression of GDF5 via the osteoarthritis susceptibility SNP rs143383. PLoS Genet., 9, e1003557
85. Bos, S.D., Bovée, J.V., Duijnisveld, B.J., Raine, E.V., van Dalen, W.J., Ramos, Y.F., van der Breggen, R., Nelissen, R.G., Slagboom, P.E., Loughlin, J. et al. (2012) Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissues. Ann. Rheum. Dis., 71, 1254-1258
86. Egli, R.J., Southam, L., Wilkins, J.M., Lorenzen, I., Pombo-Suarez, M., Gonzalez, A., Carr, A., Chapman, K. and Loughlin, J. (2009) Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism. Arthritis Rheum., 60, 2055-2064
87. Styrkarsdottir, U., Thorleifsson, G., Helgadottir, H.T., Bomer, N., Metrustry, S., Bierma-Zeinstra, S., Strijbosch, A.M., Evangelou, E., Hart, D., Beekman, M. et al. (2014) Severe osteoarthritis of the hand associates with common variants within the ALDH1A2 gene and with rare variants at 1p31. Nat. Genet., 46, 498-502
88. Gaulton, K.J., Ferreira, T., Lee, Y., Raimondo, A., Mägi, R., Reschen, M.E., Mahajan, A., Locke, A., Rayner, N.W., Robertson, N. et al. (2015) Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat. Genet., 47, 1415-1425
89. Southam, L., Rodriguez-Lopez, J., Wilkins, J.M., Pombo-Suarez, M., Snelling, S., Gomez-Reino, J.J., Chapman, K., Gonzalez, A. and Loughlin, J. (2007) An SNP in the 5'-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage. Hum. Mol. Genet., 16, 2226-2232
90. Francis-West, P.H., Abdelfattah, A., Chen, P., Allen, C., Parish, J., Ladher, R., Allen, S., MacPherson, S., Luyten, F.P. and Archer, C.W. (1999) Mechanisms of GDF-5 action during skeletal development. Development, 126, 1305-1315
91. Daans, M., Luyten, F.P. and Lories, R.J. (2011) GDF5 deficiency in mice is associated with instability-driven joint damage, gait and subchondral bone changes. Ann. Rheum. Dis., 70, 208-213
92. Enochson, L., Stenberg, J., Brittberg, M. and Lindahl, A. (2014) GDF5 reduces MMP13 expression in human chondrocytes via DKK1 mediated canonical Wnt signaling inhibition. Osteoarthr. Cartil., 22, 566-577
93. Song, R.H., Tortorella, M.D., Malfait, A.M., Alston, J.T., Yang, Z., Arner, E.C. and Griggs, D.W. (2007) Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum., 56, 575-585
94. Tetlow, L.C., Adlam, D.J. and Woolley, D.E. (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum., 44, 585-594
95. Castaño-Betancourt, M.C., Evans, D.S., Ramos, Y.F., Boer, C.G., Metrustry, S., Liu, Y., den Hollander, W., van Rooij, J., Kraus, V.B., Yau, M.S. et al. (2016) Novel Genetic Variants for Cartilage Thickness and Hip Osteoarthritis. PLoS Genet., 12, e1006260
96. Castaño Betancourt, M.C., Cailotto, F., Kerkhof, H.J., Cornelis, F.M., Doherty, S.A., Hart, D.J., Hofman, A., Luyten, F.P., Maciewicz, R.A., Mangino, M. et al. (2012) Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc. Natl. Acad. Sci. U.S.A, 109, 8218-8223
97. Evangelou, E., Valdes, A.M., Castano-Betancourt, M.C., Doherty, M., Doherty, S., Esko, T., Ingvarsson, T., Ioannidis, J.P., Kloppenburg, M., Metspalu, A. et al. (2013) The DOT1L rs12982744 polymorphism is associated with osteoarthritis of the hip with genome-wide statistical significance in males. Ann. Rheum. Dis., 72, 1264-1265
98. Liao, L., Zhang, S., Gu, J., Takarada, T., Yoneda, Y., Huang, J., Zhao, L.,Oh, C.D., Li, J.,Wang, B. et al. (2017) Deletion of Runx2 in articular chondrocytes decelerates the progression of DMM-induced osteoarthritis in adultmice. Sci. Rep., 7, 2371
99. Origins of Bone and Cartilage Disease consortium. http:// www.boneandcartilage.com/. I; date last accessed August 08, 2017
100. Ding, Q., Regan, S.N., Xia, Y., Oostrom, L.A., Cowan, C.A. and Musunuru, K. (2013) Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell, 12, 393-394
101. Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W., Marraffini, L.A. et al. (2013) Multiplex genome engineering using CRISPR/Cas systems. Science, 339, 819-823
102. Jinek, M., East, A., Cheng, A., Lin, S., Ma, E. and Doudna, J. (2013) RNA-programmed genome editing in human cells. Elife, 2, e00471
103. Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., Norville, J.E. and Church, G.M. (2013) RNA-guided human genome engineering via Cas9. Science, 339, 823-826
104. Cheng, A., Kapacee, Z., Peng, J., Lu, S., Lucas, R.J., Hardingham, T.E. and Kimber, S.J. (2014) Cartilage repair using human embryonic stem cell-derived chondroprogenitors. Stem Cells Transl. Med, 3, 1287-1294
105. Craft, A.M., Rockel, J.S., Nartiss, Y., Kandel, R.A., Alman, B.A. and Keller, G.M. (2015) Generation of articular chondrocytes from human pluripotent stem cells. Nat. Biotechnol., 33, 638-645
106. Phillips, M.D., Kuznetsov, S.A., Cherman, N., Park, K., Chen, K.G., McClendon, B.N., Hamilton, R.S., McKay, R.D., Chenoweth, J.G., Mallon, B.S. et al. (2014) Directed differentiation of human induced pluripotent stem cells toward bone and cartilage: in vitro versus in vivo assays. Stem Cells Transl. Med., 3, 867-878
107. Zhang, W., Ouyang, H., Dass, C.R. and Xu, J. (2016) Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res., 4, 15040